NCT01531647View on ClinicalTrials.gov

A Study of Drug-Drug Interaction Between Danoprevir/Low-Dose Ritonavir and Raltegravir in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions

Healthy Volunteer

Interventions

DRUG

danoprevir

100 mg q12h Days 8-21

DRUG

raltegravir

400 mg q12h Days 1-4 and 18-21

DRUG

ritonavir

100 mg q12h Days 8-21

Trial Locations (1)

66219

Lenexa

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT01531647 - A Study of Drug-Drug Interaction Between Danoprevir/Low-Dose Ritonavir and Raltegravir in Healthy Volunteers | Biotech Hunter | Biotech Hunter